Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer

Journal of Biological Chemistry(2022)10.1016/j.jbc.2022.101817Source: DataRank Database

Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer is a research paper published in Journal of Biological Chemistry (2022). On theSindex it has a DataRank of 0.815. It has been cited 21 times, with 19 citing works in its 1-hop citation network.

N/A

0.815DataRank · unranked

Scored on demand from live citation data

Open Access21 citations · 19 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 1.93)OA: goldTopics (67)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 57%Citation Network 43%

Base Score Contribution

0.464

From this paper's citation signal

Citation Network Contribution

0.351

From 18 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 19 citers.

EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy
International Journal of Molecular Sciences202218 citations50 referencesContributes 0.059
Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
International Journal of Molecular Sciences202211 citations50 referencesContributes 0.050
Recent advances in therapeutic strategies for triple-negative breast cancer
Journal of Hematology & Oncology2022928 citations179 referencesContributes 0.038
EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma
International Immunopharmacology202215 citations81 referencesContributes 0.034
EphB2-Targeting Monoclonal Antibodies Exerted Antitumor Activities in Triple-Negative Breast Cancer and Lung Mesothelioma Xenograft Models
International Journal of Molecular Sciences20254 citations56 referencesContributes 0.029

Authors (22)

Li-Chuan Chan ORCID,Ying‐Nai Wang ORCID,Yu‐Yi Chu ORCID,Chie‐Hong Wang ORCID,Heng‐Huan Lee ORCID

Live enrichment

PubMed:35278434 PMC:PMC8988001 OpenAlex:https://openalex.org/W4220939129

National Health Research Institutes

Grant: NHRI-EX110-11010BI

Breast Cancer Research Foundation

Grant: BCRF-21-070

Ministry of Science and Technology, Taiwan

Grant: MOST 109-2314-B-039-025-MY2

Ministry of Science and Technology, Taiwan

Grant: MOST 110-2639-B-039-001-ASP

Ministry of Science and Technology, Taiwan

Grant: 110-2320-B-039-065

Ministry of Science and Technology, Taiwan

Grant: 110-2314-B-039-043-MY3

Korea Advanced Institute of Science and Technology

Grant: 2021R1A4A1031856

Korea Advanced Institute of Science and Technology

Grant: 2020R1C1C1005631

National Cancer Institute

Grant: P30CA016672

China Medical University Hospital

Grant: C1090615012

National Breast Cancer Foundation

Grant: CMU108-YTY-04

National Breast Cancer Foundation

Grant: 5T32CA186892

NCI NIH HHS

Grant: T32 CA186892

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

National Institutes of Health

Grant: 5T32CA186892-05

Training Grant in Cancer Biology

NIH

Ministry of Education

Ministry of Science, ICT and Future Planning

China Medical University, Taiwan

University of Texas MD Anderson Cancer Center

National Research Foundation of Korea

FWCI

1.93

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jbc.2022.101817

publisherhttps://doi.org/10.1016/j.jbc.2022.101817

publisherhttps://api.elsevier.com/content/article/PII:S0021925822002575?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925822002575?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35278434

Fields of Study

Axon Guidance and Neuronal SignalingAngiogenesis and VEGF in CancerHER2/EGFR in Cancer Research0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntibodies, MonoclonalAntineoplastic Agents, ImmunologicalCell Line, TumorCell SurvivalDisease Models, AnimalHumansMiceReceptors, Chimeric AntigenReceptors, Eph FamilyT-LymphocytesTriple Negative Breast NeoplasmsXenograft Model Antitumor Assays

MeSH Terms

Antineoplastic Agents, ImmunologicalReceptors, Chimeric AntigenAnimalsAntibodies, MonoclonalCell SurvivalDisease Models, AnimalHumansT-LymphocytesXenograft Model Antitumor AssaysReceptors, Eph FamilyCell Line, TumorMiceTriple Negative Breast Neoplasms

Keywords

Cancer researchMonoclonal antibodyChimeric antigen receptorBiologyImmunotherapyAntigenclone (Java method)Receptor tyrosine kinaseTriple-negative breast cancerT cellBreast cancerImmunologyAntibodyReceptorCancerImmune systemAntitumor immunityTargeted TherapyCancer ImmunotherapyEphrin Receptor A10Chimeric Antigen Receptor T CellReceptors, Chimeric AntigenCell SurvivalT-LymphocytesAntibodies, MonoclonalTriple Negative Breast NeoplasmsXenograft Model Antitumor AssaysDisease Models, AnimalMiceAntineoplastic Agents, ImmunologicalCell Line, TumorAnimalsHumansResearch ArticleReceptors, Eph Family

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being